Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [[maximum depth reached]] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [[maximum depth reached]] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-trace').style.display = (document.getElementById('cakeErr67ecb68cea2dd-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecb68cea2dd-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-code').style.display = (document.getElementById('cakeErr67ecb68cea2dd-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-context').style.display = (document.getElementById('cakeErr67ecb68cea2dd-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecb68cea2dd-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67ecb68cea2dd-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> &ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> &nbsp; </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /> <br /> The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> &ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> &ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /> <br /> &ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo; </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 19607, 'metaTitle' => 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'metaKeywords' => 'medicines', 'metaDesc' => ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...', 'disp' => '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />&ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify">&nbsp;</div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /><br />The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />&ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />&ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /><br />&ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo;</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> &ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> &nbsp; </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /> <br /> The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> &ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> &ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /> <br /> &ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo; </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 19607 $metaTitle = 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan' $metaKeywords = 'medicines' $metaDesc = ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...' $disp = '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />&ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify">&nbsp;</div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /><br />The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />&ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />&ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /><br />&ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo;</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan | Im4change.org</title> <meta name="description" content=" -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Committee on drugs calls for 20 sub-panels-Vidya Krishnan</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />“The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify"> </div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /><br />The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />“We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />“It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /><br />“Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.”</div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-trace').style.display = (document.getElementById('cakeErr67ecb68cea2dd-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecb68cea2dd-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-code').style.display = (document.getElementById('cakeErr67ecb68cea2dd-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-context').style.display = (document.getElementById('cakeErr67ecb68cea2dd-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecb68cea2dd-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67ecb68cea2dd-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> &ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> &nbsp; </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /> <br /> The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> &ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> &ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /> <br /> &ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo; </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 19607, 'metaTitle' => 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'metaKeywords' => 'medicines', 'metaDesc' => ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...', 'disp' => '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />&ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify">&nbsp;</div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /><br />The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />&ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />&ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /><br />&ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo;</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> &ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> &nbsp; </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /> <br /> The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> &ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> &ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /> <br /> &ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo; </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 19607 $metaTitle = 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan' $metaKeywords = 'medicines' $metaDesc = ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...' $disp = '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />&ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify">&nbsp;</div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /><br />The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />&ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />&ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /><br />&ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo;</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan | Im4change.org</title> <meta name="description" content=" -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Committee on drugs calls for 20 sub-panels-Vidya Krishnan</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />“The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify"> </div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /><br />The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />“We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />“It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /><br />“Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.”</div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-trace').style.display = (document.getElementById('cakeErr67ecb68cea2dd-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecb68cea2dd-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-code').style.display = (document.getElementById('cakeErr67ecb68cea2dd-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecb68cea2dd-context').style.display = (document.getElementById('cakeErr67ecb68cea2dd-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecb68cea2dd-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67ecb68cea2dd-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> &ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> &nbsp; </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /> <br /> The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> &ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> &ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /> <br /> &ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo; </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 19607, 'metaTitle' => 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'metaKeywords' => 'medicines', 'metaDesc' => ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...', 'disp' => '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />&ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify">&nbsp;</div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /><br />The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />&ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />&ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /><br />&ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo;</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> &ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> &nbsp; </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /> <br /> The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> &ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> &ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /> <br /> &ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo; </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 19607 $metaTitle = 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan' $metaKeywords = 'medicines' $metaDesc = ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...' $disp = '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India&rsquo;s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn&rsquo;t appear to address the concerns raised by a parliamentary panel earlier last year that found &ldquo;sufficient evidence&rdquo; to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />&ldquo;The worst thing the committee has done is not to take any stand on any matter,&rdquo; said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify">&nbsp;</div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an &ldquo;overwhelming&rdquo; majority of the drugs in India were being approved &ldquo;on the basis of personal prescriptions and without any scientific evidence&rdquo;.<br /><br />The panel concluded that &ldquo;there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures&rdquo;.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />&ldquo;We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,&rdquo; said Katoch. &ldquo;We cannot give judgements on every matter.&rdquo;<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI&rsquo;s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />&ldquo;It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,&rdquo; Mehta said.<br /><br />&ldquo;Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.&rdquo;</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan | Im4change.org</title> <meta name="description" content=" -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Committee on drugs calls for 20 sub-panels-Vidya Krishnan</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />“The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify"> </div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /><br />The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />“We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />“It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /><br />“Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.”</div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> “The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /> <br /> The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> “We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> “It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /> <br /> “Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.” </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 19607, 'metaTitle' => 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'metaKeywords' => 'medicines', 'metaDesc' => ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...', 'disp' => '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />“The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify"> </div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /><br />The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />“We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />“It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /><br />“Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.”</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 19607, 'title' => 'Committee on drugs calls for 20 sub-panels-Vidya Krishnan', 'subheading' => '', 'description' => '<div align="justify"> -Live Mint<br /> <br /> <em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /> </em><br /> After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /> <br /> The report submitted to the health ministry in November is now in public domain following a right to information application.<br /> <br /> Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /> <br /> The panel had suggested that the health ministry restructure the drug approval process in the country.<br /> <br /> “The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /> </div> <div align="justify"> </div> <div align="justify"> A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /> <br /> The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /> <br /> The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /> <br /> The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /> <br /> The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /> <br /> This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /> <br /> “We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /> <br /> The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /> <br /> “It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /> <br /> “Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.” </div>', 'credit_writer' => 'Live Mint, 4 March, 2013, http://www.livemint.com/Politics/nsTtEPStU6q1S7gEH5Fj5N/Panel-on-drugs-calls-for-20-subpanels.html', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'committee-on-drugs-calls-for-20-sub-panels-vidya-krishnan-19745', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 19745, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 19607 $metaTitle = 'LATEST NEWS UPDATES | Committee on drugs calls for 20 sub-panels-Vidya Krishnan' $metaKeywords = 'medicines' $metaDesc = ' -Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies...' $disp = '<div align="justify">-Live Mint<br /><br /><em>An investigation found DCGI cleared drugs without conducting mandatory clinical trials<br /></em><br />After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees.<br /><br />The report submitted to the health ministry in November is now in public domain following a right to information application.<br /><br />Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials.<br /><br />The panel had suggested that the health ministry restructure the drug approval process in the country.<br /><br />“The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh.<br /></div><div align="justify"> </div><div align="justify">A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.<br /><br />The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”.<br /><br />The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”.<br /><br />The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers.<br /><br />The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them.<br /><br />This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences.<br /><br />“We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.”<br /><br />The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO.<br /><br />“It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said.<br /><br />“Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.”</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Committee on drugs calls for 20 sub-panels-Vidya Krishnan |
-Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees. The report submitted to the health ministry in November is now in public domain following a right to information application. Experts said it doesn’t appear to address the concerns raised by a parliamentary panel earlier last year that found “sufficient evidence” to establish a nexus involving medical experts, drug firms and Central Drugs Standard Control Organization (CDSCO) officials. The panel had suggested that the health ministry restructure the drug approval process in the country. “The worst thing the committee has done is not to take any stand on any matter,” said Kalpana Mehta, health activist and a petitioner in the Supreme Court on the HPV vaccine trial on tribal girls in Khammam district of Andhra Pradesh. A parliamentary committee investigation found in May that the Drugs Controller General of India (DCGI) had been approving one new drug a month on an average, without conducting mandatory clinical trials or seeking expert medical opinion.
The 18-month investigation into the functioning of the CDSCO, headed by the DCGI, revealed that an “overwhelming” majority of the drugs in India were being approved “on the basis of personal prescriptions and without any scientific evidence”. The panel concluded that “there is adequate documentary evidence to show that (expert) opinions are written by the invisible hands of drug manufacturers and experts merely oblige by putting their signatures”. The panel had picked 42 drugs randomly from the market and asked DCGI and the health ministry to furnish approval papers. The panel, which had found evidence of wrongdoing, forwarded a list of medical experts who had colluded with drug companies, suggesting that action be taken against them. This prompted the health ministry to set up the three-member committee comprising V.M. Katoch, director-general of the Indian Council of Medical Research (ICMR), P.N. Tandon, founder chairman of the National Brain Research Centre society and S.S. Agarwal, former director of the Sanjay Gandhi Postgraduate Institute of Medical Sciences. “We have tried to address all the concerns raised by the parliamentary panel. People can comment on our recommendations when the health ministry asks them to,” said Katoch. “We cannot give judgements on every matter.” The Katoch committee report makes no mention of action against doctors cited in the parliamentary panel findings. It recommends the setting up of committees for drug approval processes, fixed dosed combinations, defining DCGI’s powers and responsibilities, writing a mission statement for CDSCO and for structural and functional reorganization of CDSCO. “It has not even fixed desired qualifications for the drugs controller but has asked for formation of committees and consultants in every matter raised unequivocally by the parliamentary panel,” Mehta said. “Meanwhile, no drugs have been banned, no consumer information has been made available and no errant person or company has even been charge-sheeted.” |